AG 041R
Latest Information Update: 18 Jul 2006
Price :
$50 *
At a glance
- Originator Chugai Pharmaceutical
- Class Antiulcers
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoarthritis; Peptic ulcer